Global health R&D benefits rich countries too, study argues
A 14-year old girl in Addis Ababa getting the HPV vaccine during the HPV vaccine in January 2021. Photo credits: WHO As the US cuts back on its funding for global health research, a new study has argued that this money largely stays within rich countries, and leads to inventions that are later repurposed for people in wealthy, donor states. Under Donald.
